期刊文献+

胃癌患者外周血中骨桥蛋白和基质金属蛋白酶-9的含量分析及临床意义 被引量:5

Plasma level and clinical significance of osteopontin and matrix metalloproteinase-9 in gastric cancer patients
原文传递
导出
摘要 目的 探讨骨桥蛋白(OPN)和基质金属蛋白酶-9(MMP-9)在胃癌患者外周血中的含量变化及其临床意义.方法 采用双抗体夹心ABC-ELISA法检测51例胃癌患者、29例慢性萎缩性胃炎患者、31例健康者和29例胃癌术后6~12个月随访者外周血中的OPN和MMP-9的含量;应用免疫组织化学方法检测28例胃癌组织中OPN和MMP-9的表达.结果 胃癌患者外周血中OPN和MMP-9的含量明显高于健康者和慢性萎缩性胃炎;胃癌患者外周血中OPN和MMP-9的含量与胃癌的临床分期及预后明显相关,而与性别、年龄、肿瘤大小及分化程度无关;胃癌组织中OPN和MMP-9高表达,外周血中OPN和MMP-9存在相关性.结论 检测外周血中OPN和MMP-9的含量对胃癌的诊断、治疗、预后评估及病情监测有重要意义. Objeclive To investigate the plasma level and clinical significance of osteopontinand (OPN) and matrix metalloproteinase-9 (MMP-9)in patients with gastric cancer. Methods Plasma level of osteopontin and matrix metalloproteinase-9 were detected by ABC-ELISA method in 51 patients with gastric eaneer、29 patients with chronic atrophic gsstritis、 31 normal peoples and 29 patients with gastric cancer cut away;The expression of OPN and MMP-9 was examined by immunohistoehemistry method. Results The plasma leverlevel of OPN and MMP-9 in gastric cancer group was higher than that in normal group or chronic atrophic gastritis. The plasma leverlevel of OPN and MMP-9 in gastric cancer patients was correlated with clinical stage and prognosis, but not correlation with sex, age, size or differentiated degree of tumour;Preoperative and postoperative plasma levels of OPN and MMP-9 in gastric cancer group were obviously different;There were also some correlations between OPN and MMP-9 plasma level. Conclusion To detect Detection of the plasma levels of OPN and MMP-9 in gastric cancer patients has greatly clinical significance in the treatment diagnosis prognois evaluation and monitoring for gastric cancer patients.
出处 《临床内科杂志》 CAS 2007年第8期524-526,共3页 Journal of Clinical Internal Medicine
关键词 胃癌 骨桥蛋白 基质金属蛋白酶-9 外周血 Gastric cancer Osteopontin Matrix metalloproteinase-9 Plasma
  • 相关文献

参考文献11

二级参考文献24

  • 1[1]Crawford HC,Matrisian LM,Liaw L. Distinct role of osteopontin in host defense activity and tumor survival during sqamous cell carcinoma progression in vivo[J].Cancer Res,1998,58(22):5206-5215.
  • 2[2]Takahashi F,Takahashi K,Maeda K,et al. Osteopontin is induced by nitric oxide in RAW264.7 cells[J].IUBMB Life,2000,49(2):217-221.
  • 3[3]Denhardt DT,Giachelli CM,Rittling SR. Role of Osteopontin in celluar signaling ang toxicant injury[J].Ann Rev Pharmacol Toxicol,2001,41(3):723-749.
  • 4[4]Oidberg A,Franzen A,Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding seqence[J].Proc Natl Acad Sci USA,1986,83(5):8819-8823.
  • 5[5]Tuck AB,O'Malley FP,Singhal H,et al. Osteopontin expression in a group of lymph node negative breast cancer patients[J].Int J Cancer (Pred Oncol),1998,79(4):502-508.
  • 6[6]Agrawal D,Chen T,Irby R,et al. Osteopontin identified as lead marker of colon cancer progression,using pooled sample expression profiling[J].J Natl Cancer Inst,2002,94(7):513-521.
  • 7[7]Teruyoshi UE,Yokozaki H,Kitadai Y,et al. Co-Expression of osteopontin and CD44V9 in gastric cancer[J].Int J Cancer,1998,79(1):127-132.
  • 8[8]Craig AM,Bowden GT,Chambers AF,et al. Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts[J].Int J Cancer,1990,46(1):133-137.
  • 9[9]Behrend EI,Craig AM,Wilson SM,et al. Reduced malignancy of ras-transformed NIH3T3 cells expressing antisense osteopontin RNA[J].Cancer Res,1994,54(3):832-837.
  • 10[10]Scorilas A,Karameris A,Arnogiannaki N,et al. Overexpression of matrix-metalloproteinase-9 in human breast cancer:a potential favourable indicator in node-negative patients[J].Br J Cancer,2001,84(11):1488-1496.

共引文献40

同被引文献82

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部